

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.99030079 |
| 2 | viral transcription (GO:0019083) | 6.06128572 |
| 3 | translational termination (GO:0006415) | 5.83432018 |
| 4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.77204186 |
| 5 | cotranslational protein targeting to membrane (GO:0006613) | 5.72120700 |
| 6 | protein targeting to ER (GO:0045047) | 5.66222944 |
| 7 | protein localization to endoplasmic reticulum (GO:0070972) | 5.43893969 |
| 8 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.39887209 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 5.39378821 |
| 10 | translational elongation (GO:0006414) | 4.91377909 |
| 11 | viral life cycle (GO:0019058) | 4.62897249 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.49301603 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.49301603 |
| 14 | signal peptide processing (GO:0006465) | 4.43679213 |
| 15 | cellular protein complex disassembly (GO:0043624) | 4.34334435 |
| 16 | DNA deamination (GO:0045006) | 4.25748445 |
| 17 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.25388465 |
| 18 | maturation of SSU-rRNA (GO:0030490) | 4.23883955 |
| 19 | negative regulation of protein activation cascade (GO:2000258) | 4.15185698 |
| 20 | regulation of protein activation cascade (GO:2000257) | 4.02867966 |
| 21 | translational initiation (GO:0006413) | 4.02257384 |
| 22 | regulation of complement activation (GO:0030449) | 3.99793175 |
| 23 | negative regulation of complement activation (GO:0045916) | 3.95988545 |
| 24 | platelet dense granule organization (GO:0060155) | 3.90319838 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 3.86940633 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.86940633 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83287109 |
| 28 | protein targeting to membrane (GO:0006612) | 3.81412292 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80654149 |
| 30 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76433547 |
| 31 | ribosomal large subunit biogenesis (GO:0042273) | 3.76202177 |
| 32 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.69598589 |
| 33 | protein complex disassembly (GO:0043241) | 3.63306048 |
| 34 | protein maturation by protein folding (GO:0022417) | 3.58029565 |
| 35 | intestinal cholesterol absorption (GO:0030299) | 3.56327040 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55014308 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.55014308 |
| 38 | COPI coating of Golgi vesicle (GO:0048205) | 3.51117730 |
| 39 | Golgi transport vesicle coating (GO:0048200) | 3.51117730 |
| 40 | regulation of fibrinolysis (GO:0051917) | 3.50850095 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.47992068 |
| 42 | translation (GO:0006412) | 3.47128960 |
| 43 | macromolecular complex disassembly (GO:0032984) | 3.40868183 |
| 44 | protein carboxylation (GO:0018214) | 3.38433276 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38433276 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31994332 |
| 47 | desmosome organization (GO:0002934) | 3.28372818 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 3.23218831 |
| 49 | respiratory chain complex IV assembly (GO:0008535) | 3.20695059 |
| 50 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.20208960 |
| 51 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.18787616 |
| 52 | proteasome assembly (GO:0043248) | 3.16569815 |
| 53 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.10302127 |
| 54 | daunorubicin metabolic process (GO:0044597) | 3.06567279 |
| 55 | polyketide metabolic process (GO:0030638) | 3.06567279 |
| 56 | doxorubicin metabolic process (GO:0044598) | 3.06567279 |
| 57 | mRNA catabolic process (GO:0006402) | 3.06223959 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.04311692 |
| 59 | GPI anchor biosynthetic process (GO:0006506) | 3.04213152 |
| 60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.02823175 |
| 61 | response to interferon-beta (GO:0035456) | 3.00579799 |
| 62 | surfactant homeostasis (GO:0043129) | 3.00354276 |
| 63 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.99968884 |
| 64 | fibrinolysis (GO:0042730) | 2.96603972 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.93827006 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 2.92052884 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.91931359 |
| 68 | negative regulation of norepinephrine secretion (GO:0010700) | 2.88959327 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87408722 |
| 70 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.87039267 |
| 71 | fucose catabolic process (GO:0019317) | 2.84962027 |
| 72 | L-fucose metabolic process (GO:0042354) | 2.84962027 |
| 73 | L-fucose catabolic process (GO:0042355) | 2.84962027 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 2.83993756 |
| 75 | mannosylation (GO:0097502) | 2.82680750 |
| 76 | fatty acid elongation (GO:0030497) | 2.80716189 |
| 77 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.80669601 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 2.79875078 |
| 79 | macromolecular complex remodeling (GO:0034367) | 2.79875078 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 2.79875078 |
| 81 | reverse cholesterol transport (GO:0043691) | 2.79082586 |
| 82 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.77898157 |
| 83 | intestinal absorption (GO:0050892) | 2.77291950 |
| 84 | COPII vesicle coating (GO:0048208) | 2.77257170 |
| 85 | RNA catabolic process (GO:0006401) | 2.77175044 |
| 86 | proline biosynthetic process (GO:0006561) | 2.74969411 |
| 87 | lymphoid progenitor cell differentiation (GO:0002320) | 2.74715165 |
| 88 | definitive hemopoiesis (GO:0060216) | 2.74503718 |
| 89 | telomere maintenance via recombination (GO:0000722) | 2.73033290 |
| 90 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71501379 |
| 91 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.68658219 |
| 92 | termination of RNA polymerase III transcription (GO:0006386) | 2.65953941 |
| 93 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.65953941 |
| 94 | L-ascorbic acid metabolic process (GO:0019852) | 2.63415214 |
| 95 | cholesterol efflux (GO:0033344) | 2.62774366 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 2.62489851 |
| 97 | ER overload response (GO:0006983) | 2.62343224 |
| 98 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.61783969 |
| 99 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.61652810 |
| 100 | cholesterol biosynthetic process (GO:0006695) | 2.60492868 |
| 101 | establishment of protein localization to membrane (GO:0090150) | 2.59262352 |
| 102 | cytochrome complex assembly (GO:0017004) | 2.59082875 |
| 103 | DNA strand elongation (GO:0022616) | 2.58481242 |
| 104 | proline metabolic process (GO:0006560) | 2.51787868 |
| 105 | cellular zinc ion homeostasis (GO:0006882) | 2.51252649 |
| 106 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.50395024 |
| 107 | regulation of respiratory burst (GO:0060263) | 2.49975696 |
| 108 | cellular component biogenesis (GO:0044085) | 2.49750602 |
| 109 | mast cell activation (GO:0045576) | 2.48943746 |
| 110 | negative regulation of coagulation (GO:0050819) | 2.48652734 |
| 111 | sterol biosynthetic process (GO:0016126) | 2.48595000 |
| 112 | negative regulation of hemostasis (GO:1900047) | 2.48142189 |
| 113 | negative regulation of blood coagulation (GO:0030195) | 2.48142189 |
| 114 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47619307 |
| 115 | intestinal epithelial cell development (GO:0060576) | 2.46109969 |
| 116 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.45812405 |
| 117 | negative regulation of humoral immune response (GO:0002921) | 2.45340070 |
| 118 | GPI anchor metabolic process (GO:0006505) | 2.45279512 |
| 119 | regulation of cholesterol homeostasis (GO:2000188) | 2.44721202 |
| 120 | protein targeting (GO:0006605) | 2.44644279 |
| 121 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.43991594 |
| 122 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.43097099 |
| 123 | 4-hydroxyproline metabolic process (GO:0019471) | 2.42882840 |
| 124 | formation of translation preinitiation complex (GO:0001731) | 2.42853464 |
| 125 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.41842272 |
| 126 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.41790814 |
| 127 | NADH dehydrogenase complex assembly (GO:0010257) | 2.41790814 |
| 128 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.41790814 |
| 129 | ribosome assembly (GO:0042255) | 2.41471586 |
| 130 | positive regulation of chemokine secretion (GO:0090197) | 2.40832207 |
| 131 | chemical homeostasis within a tissue (GO:0048875) | 2.40801728 |
| 132 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.40629888 |
| 133 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.40396137 |
| 134 | plasma lipoprotein particle organization (GO:0071827) | 2.39950885 |
| 135 | gap junction assembly (GO:0016264) | 2.39935615 |
| 136 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.39809580 |
| 137 | sphingoid metabolic process (GO:0046519) | 2.39773026 |
| 138 | pseudouridine synthesis (GO:0001522) | 2.39755442 |
| 139 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.39335781 |
| 140 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.38552942 |
| 141 | zinc ion transmembrane transport (GO:0071577) | 2.36805505 |
| 142 | protein-lipid complex assembly (GO:0065005) | 2.36611756 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.36500068 |
| 144 | protein neddylation (GO:0045116) | 2.36055435 |
| 145 | amyloid precursor protein catabolic process (GO:0042987) | 2.35798688 |
| 146 | regulation of metalloenzyme activity (GO:0048552) | 2.35719483 |
| 147 | positive regulation of B cell differentiation (GO:0045579) | 2.35089160 |
| 148 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.35009031 |
| 149 | peptidyl-histidine modification (GO:0018202) | 2.34973720 |
| 150 | sterol transport (GO:0015918) | 2.34668759 |
| 151 | cholesterol transport (GO:0030301) | 2.34668759 |
| 152 | alpha-linolenic acid metabolic process (GO:0036109) | 2.34166418 |
| 153 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.33774551 |
| 154 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.33774551 |
| 155 | mitotic recombination (GO:0006312) | 2.33768376 |
| 156 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.33255798 |
| 157 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.33237809 |
| 158 | positive regulation of respiratory burst (GO:0060267) | 2.33029270 |
| 159 | purine ribonucleotide transport (GO:0015868) | 2.32748638 |
| 160 | cysteine metabolic process (GO:0006534) | 2.32525783 |
| 161 | primary alcohol catabolic process (GO:0034310) | 2.32524260 |
| 162 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.31998357 |
| 163 | negative regulation of ligase activity (GO:0051352) | 2.31596624 |
| 164 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.31596624 |
| 165 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.31592358 |
| 166 | rRNA processing (GO:0006364) | 2.31207100 |
| 167 | cellular copper ion homeostasis (GO:0006878) | 2.30481548 |
| 168 | tyrosine metabolic process (GO:0006570) | 2.30227650 |
| 169 | protein complex biogenesis (GO:0070271) | 2.30094566 |
| 170 | retinal metabolic process (GO:0042574) | 2.30068703 |
| 171 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.29958622 |
| 172 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.29949600 |
| 173 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.29949600 |
| 174 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.29949600 |
| 175 | negative regulation of wound healing (GO:0061045) | 2.29637472 |
| 176 | regulation of mitochondrial translation (GO:0070129) | 2.29355999 |
| 177 | fructose metabolic process (GO:0006000) | 2.29029271 |
| 178 | cellular glucuronidation (GO:0052695) | 2.28622442 |
| 179 | C-terminal protein lipidation (GO:0006501) | 2.28343350 |
| 180 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.28223262 |
| 181 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.28095134 |
| 182 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.26262157 |
| 183 | tricarboxylic acid cycle (GO:0006099) | 2.24325242 |
| 184 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.24091464 |
| 185 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.22780226 |
| 186 | protein hydroxylation (GO:0018126) | 2.21931473 |
| 187 | establishment of integrated proviral latency (GO:0075713) | 2.21832249 |
| 188 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.21123365 |
| 189 | uronic acid metabolic process (GO:0006063) | 2.20456981 |
| 190 | glucuronate metabolic process (GO:0019585) | 2.20456981 |
| 191 | glycoside metabolic process (GO:0016137) | 2.19682149 |
| 192 | peptidyl-proline hydroxylation (GO:0019511) | 2.19400330 |
| 193 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.18948163 |
| 194 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.18347558 |
| 195 | membrane budding (GO:0006900) | 2.18259542 |
| 196 | protein activation cascade (GO:0072376) | 2.17742535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.64229447 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.07790132 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.39616171 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.30048279 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.25601745 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23918990 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18208193 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.96372446 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.92590202 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.88827399 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.88709715 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.84969182 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.83988893 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.73216391 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.69903663 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.68275658 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63360150 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.58758930 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56069883 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.53157069 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.44186373 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37289511 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.36401847 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35246579 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.35037324 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33926184 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.31332151 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31136203 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29160451 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25328339 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20959941 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.18622934 |
| 33 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.17868930 |
| 34 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.17241071 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14977800 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.14364995 |
| 37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.12559698 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.09489881 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01914662 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98810934 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.98644267 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98460711 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93615768 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.92300781 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.89888462 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.87865675 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.86104604 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85225496 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.84230647 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83750629 |
| 51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.83587221 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83405755 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.80536931 |
| 54 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.79799544 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.76939701 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.75469104 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.74739350 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73949749 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73011485 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70116109 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.69768046 |
| 62 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69621476 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69543975 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.68972789 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.66153449 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65977666 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.64958104 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64060992 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62812133 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.61692512 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60962917 |
| 72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.60439300 |
| 73 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.55389224 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55321916 |
| 75 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.54596982 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53880326 |
| 77 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.52221318 |
| 78 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.51897250 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47920287 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47089009 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44493074 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.44342613 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44212157 |
| 84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.41717929 |
| 85 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.39332057 |
| 86 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37931923 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.37015122 |
| 88 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.36802517 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35215010 |
| 90 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.34887698 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34497546 |
| 92 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.34252386 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34164778 |
| 94 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.33969677 |
| 95 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32533161 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31196270 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31121480 |
| 98 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30038144 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.29459082 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28095220 |
| 101 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.28041715 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26979126 |
| 103 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26962929 |
| 104 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25477843 |
| 105 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23413069 |
| 106 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23231740 |
| 107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22637570 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22483878 |
| 109 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20372972 |
| 110 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.18315992 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18050726 |
| 112 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17782531 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17710497 |
| 114 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16423197 |
| 115 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16133622 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15942893 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14314785 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13406535 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.13378798 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12722533 |
| 121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12042798 |
| 122 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09739939 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09676807 |
| 124 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09447465 |
| 125 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.09205464 |
| 126 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08995914 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08961950 |
| 128 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.08779875 |
| 129 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07958122 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07097790 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06108068 |
| 132 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05729874 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05502493 |
| 134 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05242311 |
| 135 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04929591 |
| 136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04545298 |
| 137 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03023217 |
| 138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03011487 |
| 139 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02450005 |
| 140 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02361684 |
| 141 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02361684 |
| 142 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.02311466 |
| 143 | MYB_26560356_Chip-Seq_TH1_Human | 1.00292767 |
| 144 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.00086606 |
| 145 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99961322 |
| 146 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99099073 |
| 147 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98883423 |
| 148 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.97197527 |
| 149 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96780163 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96262385 |
| 151 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92849682 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92838475 |
| 153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90504210 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.90329579 |
| 155 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90022224 |
| 156 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89971183 |
| 157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88471323 |
| 158 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87560102 |
| 159 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87188967 |
| 160 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86963619 |
| 161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85298867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.52429674 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.53880978 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.33360890 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.14699969 |
| 5 | MP0005365_abnormal_bile_salt | 2.97515858 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.91384558 |
| 7 | MP0006054_spinal_hemorrhage | 2.85689305 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.77890211 |
| 9 | MP0009785_altered_susceptibility_to | 2.77168189 |
| 10 | MP0003724_increased_susceptibility_to | 2.57355867 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.46730100 |
| 12 | MP0003868_abnormal_feces_composition | 2.46639418 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45111989 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.42315116 |
| 15 | MP0000465_gastrointestinal_hemorrhage | 2.40698992 |
| 16 | MP0003941_abnormal_skin_development | 2.40478610 |
| 17 | MP0005671_abnormal_response_to | 2.36820062 |
| 18 | MP0003122_maternal_imprinting | 2.36095023 |
| 19 | MP0004381_abnormal_hair_follicle | 2.30535743 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.28492858 |
| 21 | MP0005025_abnormal_response_to | 2.28329006 |
| 22 | MP0003123_paternal_imprinting | 2.28309019 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.20111634 |
| 24 | MP0000685_abnormal_immune_system | 2.19848667 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 2.17513832 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.07831313 |
| 27 | MP0003763_abnormal_thymus_physiology | 2.04987689 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.04088006 |
| 29 | MP0003195_calcinosis | 1.98984500 |
| 30 | MP0004272_abnormal_basement_membrane | 1.96364028 |
| 31 | MP0002419_abnormal_innate_immunity | 1.95962476 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.95327795 |
| 33 | MP0003436_decreased_susceptibility_to | 1.93898862 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.91963669 |
| 35 | MP0002723_abnormal_immune_serum | 1.88695606 |
| 36 | MP0003186_abnormal_redox_activity | 1.88643497 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.82927000 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.82036868 |
| 39 | MP0001819_abnormal_immune_cell | 1.79896328 |
| 40 | MP0001800_abnormal_humoral_immune | 1.79615919 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.79307915 |
| 42 | MP0003566_abnormal_cell_adhesion | 1.76880802 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.74935708 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.69312832 |
| 45 | MP0004147_increased_porphyrin_level | 1.66659104 |
| 46 | MP0000490_abnormal_crypts_of | 1.63634301 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.60160747 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.60160747 |
| 49 | MP0005332_abnormal_amino_acid | 1.58503527 |
| 50 | MP0002006_tumorigenesis | 1.54551163 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.53998871 |
| 52 | MP0005360_urolithiasis | 1.53570104 |
| 53 | MP0001853_heart_inflammation | 1.53362908 |
| 54 | MP0002796_impaired_skin_barrier | 1.53121594 |
| 55 | MP0005387_immune_system_phenotype | 1.53085967 |
| 56 | MP0001790_abnormal_immune_system | 1.53085967 |
| 57 | MP0002398_abnormal_bone_marrow | 1.52128492 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.49015915 |
| 59 | MP0000716_abnormal_immune_system | 1.45875288 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.43739265 |
| 61 | MP0004947_skin_inflammation | 1.43131856 |
| 62 | MP0005083_abnormal_biliary_tract | 1.42839455 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.40760463 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.39614154 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.38639899 |
| 66 | MP0006082_CNS_inflammation | 1.36540136 |
| 67 | MP0002722_abnormal_immune_system | 1.35885092 |
| 68 | MP0002132_abnormal_respiratory_system | 1.35475096 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.35323077 |
| 70 | MP0002009_preneoplasia | 1.35050952 |
| 71 | MP0002429_abnormal_blood_cell | 1.33492300 |
| 72 | MP0001873_stomach_inflammation | 1.33143125 |
| 73 | MP0008469_abnormal_protein_level | 1.30962201 |
| 74 | MP0005257_abnormal_intraocular_pressure | 1.29841638 |
| 75 | MP0002405_respiratory_system_inflammati | 1.28011668 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 1.25995148 |
| 77 | MP0003315_abnormal_perineum_morphology | 1.25587579 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.25213715 |
| 79 | MP0002060_abnormal_skin_morphology | 1.24654125 |
| 80 | MP0008932_abnormal_embryonic_tissue | 1.22408041 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.20520169 |
| 82 | MP0000566_synostosis | 1.20082348 |
| 83 | MP0003718_maternal_effect | 1.19474203 |
| 84 | MP0000383_abnormal_hair_follicle | 1.19361744 |
| 85 | MP0003866_abnormal_defecation | 1.18975116 |
| 86 | MP0003011_delayed_dark_adaptation | 1.18746119 |
| 87 | MP0004957_abnormal_blastocyst_morpholog | 1.17487600 |
| 88 | MP0005501_abnormal_skin_physiology | 1.17368073 |
| 89 | MP0005409_darkened_coat_color | 1.16180450 |
| 90 | MP0008007_abnormal_cellular_replicative | 1.15010316 |
| 91 | MP0001216_abnormal_epidermal_layer | 1.13132229 |
| 92 | MP0003950_abnormal_plasma_membrane | 1.12845993 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 1.11797668 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 1.11759868 |
| 95 | MP0001533_abnormal_skeleton_physiology | 1.08938969 |
| 96 | MP0000920_abnormal_myelination | 1.08907713 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 1.07324335 |
| 98 | MP0000013_abnormal_adipose_tissue | 1.06829154 |
| 99 | MP0000627_abnormal_mammary_gland | 1.06669861 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 1.05808322 |
| 101 | MP0002933_joint_inflammation | 1.05619893 |
| 102 | MP0001881_abnormal_mammary_gland | 1.04666486 |
| 103 | MP0005408_hypopigmentation | 1.04503156 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 1.04474566 |
| 105 | MP0001764_abnormal_homeostasis | 1.04222258 |
| 106 | MP0001986_abnormal_taste_sensitivity | 1.03640429 |
| 107 | MP0005187_abnormal_penis_morphology | 1.03282938 |
| 108 | MP0003638_abnormal_response/metabolism_ | 1.03017424 |
| 109 | MP0000609_abnormal_liver_physiology | 1.02943649 |
| 110 | MP0001851_eye_inflammation | 1.00557164 |
| 111 | MP0000358_abnormal_cell_content/ | 0.98884979 |
| 112 | MP0000579_abnormal_nail_morphology | 0.97522003 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.94766384 |
| 114 | MP0002098_abnormal_vibrissa_morphology | 0.93567403 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.92668614 |
| 116 | MP0002938_white_spotting | 0.92244074 |
| 117 | MP0000858_altered_metastatic_potential | 0.91001182 |
| 118 | MP0009697_abnormal_copulation | 0.90711795 |
| 119 | MP0010094_abnormal_chromosome_stability | 0.90337686 |
| 120 | MP0009672_abnormal_birth_weight | 0.89949855 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.89571846 |
| 122 | MP0000343_altered_response_to | 0.89561890 |
| 123 | MP0000647_abnormal_sebaceous_gland | 0.89216863 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.89207837 |
| 125 | MP0004019_abnormal_vitamin_homeostasis | 0.88970038 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.88957016 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.88875825 |
| 128 | MP0001756_abnormal_urination | 0.88621345 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.86131244 |
| 130 | MP0003890_abnormal_embryonic-extraembry | 0.85933972 |
| 131 | MP0001730_embryonic_growth_arrest | 0.85480209 |
| 132 | MP0005451_abnormal_body_composition | 0.85311478 |
| 133 | MP0002019_abnormal_tumor_incidence | 0.84655885 |
| 134 | MP0002160_abnormal_reproductive_system | 0.83462661 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.83377299 |
| 136 | MP0002089_abnormal_postnatal_growth/wei | 0.83228094 |
| 137 | MP0000467_abnormal_esophagus_morphology | 0.83065856 |
| 138 | MP0005275_abnormal_skin_tensile | 0.82753302 |
| 139 | MP0010678_abnormal_skin_adnexa | 0.82425328 |
| 140 | MP0005248_abnormal_Harderian_gland | 0.82273747 |
| 141 | MP0005636_abnormal_mineral_homeostasis | 0.82163093 |
| 142 | MP0001191_abnormal_skin_condition | 0.81883756 |
| 143 | MP0010771_integument_phenotype | 0.81784144 |
| 144 | MP0001915_intracranial_hemorrhage | 0.81615808 |
| 145 | MP0001697_abnormal_embryo_size | 0.80747864 |
| 146 | MP0000537_abnormal_urethra_morphology | 0.80566509 |
| 147 | MP0000377_abnormal_hair_follicle | 0.80284287 |
| 148 | MP0001661_extended_life_span | 0.79764694 |
| 149 | MP0003252_abnormal_bile_duct | 0.79687455 |
| 150 | MP0009840_abnormal_foam_cell | 0.79501273 |
| 151 | MP0006036_abnormal_mitochondrial_physio | 0.78960402 |
| 152 | MP0009763_increased_sensitivity_to | 0.78378421 |
| 153 | MP0002697_abnormal_eye_size | 0.77042955 |
| 154 | MP0005220_abnormal_exocrine_pancreas | 0.76857470 |
| 155 | MP0001243_abnormal_dermal_layer | 0.75897390 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.75727528 |
| 157 | MP0009931_abnormal_skin_appearance | 0.75370316 |
| 158 | MP0002086_abnormal_extraembryonic_tissu | 0.73797530 |
| 159 | MP0003984_embryonic_growth_retardation | 0.72972376 |
| 160 | MP0000639_abnormal_adrenal_gland | 0.71647771 |
| 161 | MP0002896_abnormal_bone_mineralization | 0.70797914 |
| 162 | MP0002088_abnormal_embryonic_growth/wei | 0.69721786 |
| 163 | MP0005380_embryogenesis_phenotype | 0.69465368 |
| 164 | MP0001672_abnormal_embryogenesis/_devel | 0.69465368 |
| 165 | MP0003942_abnormal_urinary_system | 0.69245840 |
| 166 | MP0010368_abnormal_lymphatic_system | 0.69194193 |
| 167 | MP0009053_abnormal_anal_canal | 0.69038060 |
| 168 | MP0003136_yellow_coat_color | 0.68591527 |
| 169 | MP0005410_abnormal_fertilization | 0.67301070 |
| 170 | MP0002295_abnormal_pulmonary_circulatio | 0.66775654 |
| 171 | MP0005076_abnormal_cell_differentiation | 0.65991747 |
| 172 | MP0002090_abnormal_vision | 0.64531463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.51105503 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.35499957 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.09054087 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 4.79219589 |
| 5 | Reticulocytopenia (HP:0001896) | 4.26173516 |
| 6 | Thrombocytosis (HP:0001894) | 3.90627300 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86529966 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.75764317 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.73187113 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.65247252 |
| 11 | Aplastic anemia (HP:0001915) | 3.62451208 |
| 12 | Type I transferrin isoform profile (HP:0003642) | 3.59231809 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 3.55388299 |
| 14 | Vascular calcification (HP:0004934) | 3.37919888 |
| 15 | IgM deficiency (HP:0002850) | 3.34678070 |
| 16 | Macrocytic anemia (HP:0001972) | 3.29442350 |
| 17 | Petechiae (HP:0000967) | 3.29337915 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.26237240 |
| 19 | Asymmetry of the thorax (HP:0001555) | 3.25435602 |
| 20 | Glomerulonephritis (HP:0000099) | 3.20273366 |
| 21 | Complement deficiency (HP:0004431) | 3.19687567 |
| 22 | Pallor (HP:0000980) | 3.19395139 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.15975318 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.15052843 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.14786343 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.07612731 |
| 27 | Chronic otitis media (HP:0000389) | 3.04196018 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 3.03300147 |
| 29 | Abnormal glycosylation (HP:0012345) | 3.03300147 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.03300147 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.03300147 |
| 32 | Myositis (HP:0100614) | 3.00828448 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.99149030 |
| 34 | Hepatic necrosis (HP:0002605) | 2.98703746 |
| 35 | 3-Methylglutaconic aciduria (HP:0003535) | 2.96467895 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 2.94767184 |
| 37 | Parakeratosis (HP:0001036) | 2.92347511 |
| 38 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.92224736 |
| 39 | Renal Fanconi syndrome (HP:0001994) | 2.90223874 |
| 40 | Increased hepatocellular lipid droplets (HP:0006565) | 2.89793290 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.88437549 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86825724 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.86077529 |
| 44 | Xanthomatosis (HP:0000991) | 2.84429770 |
| 45 | Menorrhagia (HP:0000132) | 2.84199033 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.81597160 |
| 47 | Erythema (HP:0010783) | 2.81555077 |
| 48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.81098173 |
| 49 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.74138520 |
| 50 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.74138520 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 2.70389871 |
| 52 | Joint hemorrhage (HP:0005261) | 2.63172951 |
| 53 | Mitochondrial inheritance (HP:0001427) | 2.62729185 |
| 54 | Exertional dyspnea (HP:0002875) | 2.62714251 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.59878902 |
| 56 | Hyperalaninemia (HP:0003348) | 2.59878902 |
| 57 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59878902 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.59114140 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.51089428 |
| 60 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.49575663 |
| 61 | Hypolipoproteinemia (HP:0010981) | 2.48700696 |
| 62 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.46998921 |
| 63 | Abnormal tarsal ossification (HP:0008369) | 2.43493083 |
| 64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.43224263 |
| 65 | Abnormality of complement system (HP:0005339) | 2.43041439 |
| 66 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41638740 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.35016176 |
| 68 | Megaloblastic anemia (HP:0001889) | 2.31947038 |
| 69 | Recurrent bronchitis (HP:0002837) | 2.31733161 |
| 70 | Purpura (HP:0000979) | 2.31547708 |
| 71 | Abnormality of T cell physiology (HP:0011840) | 2.30930672 |
| 72 | Systemic lupus erythematosus (HP:0002725) | 2.29019510 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.27660013 |
| 74 | Patchy hypopigmentation of hair (HP:0011365) | 2.27519070 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.26977288 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.26839786 |
| 77 | Increased muscle lipid content (HP:0009058) | 2.26105344 |
| 78 | Spontaneous abortion (HP:0005268) | 2.22620953 |
| 79 | Increased CSF lactate (HP:0002490) | 2.21945302 |
| 80 | Small epiphyses (HP:0010585) | 2.20508328 |
| 81 | Abnormality of carpal bone ossification (HP:0006257) | 2.19985117 |
| 82 | Abnormality of the intrinsic pathway (HP:0010989) | 2.19495282 |
| 83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19430860 |
| 84 | Microcytic anemia (HP:0001935) | 2.19329511 |
| 85 | Pancytopenia (HP:0001876) | 2.19015084 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.18244757 |
| 87 | B lymphocytopenia (HP:0010976) | 2.16991695 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.16991695 |
| 89 | Flat acetabular roof (HP:0003180) | 2.16276868 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.16257327 |
| 91 | Abnormal hemoglobin (HP:0011902) | 2.15649800 |
| 92 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.13252969 |
| 93 | Septate vagina (HP:0001153) | 2.10633982 |
| 94 | IgG deficiency (HP:0004315) | 2.10006592 |
| 95 | Acute necrotizing encephalopathy (HP:0006965) | 2.09530779 |
| 96 | Fat malabsorption (HP:0002630) | 2.09469703 |
| 97 | Hyperammonemia (HP:0001987) | 2.08356884 |
| 98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.06451761 |
| 99 | Epidermoid cyst (HP:0200040) | 2.05910473 |
| 100 | Eczematoid dermatitis (HP:0000976) | 2.05573001 |
| 101 | Prolonged bleeding time (HP:0003010) | 2.04996771 |
| 102 | Recurrent skin infections (HP:0001581) | 2.03754765 |
| 103 | Gout (HP:0001997) | 2.03230019 |
| 104 | Respiratory difficulties (HP:0002880) | 2.00708090 |
| 105 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98878804 |
| 106 | Mitral stenosis (HP:0001718) | 1.98463973 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 1.97531629 |
| 108 | Abnormality of secondary sexual hair (HP:0009888) | 1.97446338 |
| 109 | Abnormality of the axillary hair (HP:0100134) | 1.97446338 |
| 110 | Beaking of vertebral bodies (HP:0004568) | 1.97252512 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 1.95738838 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95503390 |
| 113 | Microglossia (HP:0000171) | 1.94969302 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 1.94667563 |
| 115 | Conjunctival hamartoma (HP:0100780) | 1.94093683 |
| 116 | Sparse eyelashes (HP:0000653) | 1.93523143 |
| 117 | Pheochromocytoma (HP:0002666) | 1.92692237 |
| 118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92656854 |
| 119 | Back pain (HP:0003418) | 1.92257962 |
| 120 | Hypothermia (HP:0002045) | 1.91903534 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.91412071 |
| 122 | Abnormality of the prostate (HP:0008775) | 1.90789408 |
| 123 | Hypoproteinemia (HP:0003075) | 1.90296000 |
| 124 | Cerebral edema (HP:0002181) | 1.89428054 |
| 125 | Congenital, generalized hypertrichosis (HP:0004540) | 1.89307488 |
| 126 | Acute encephalopathy (HP:0006846) | 1.88474899 |
| 127 | Termporal pattern (HP:0011008) | 1.88456263 |
| 128 | Insidious onset (HP:0003587) | 1.88456263 |
| 129 | Microretrognathia (HP:0000308) | 1.88310778 |
| 130 | Acanthocytosis (HP:0001927) | 1.88289371 |
| 131 | White forelock (HP:0002211) | 1.86971618 |
| 132 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86819821 |
| 133 | Epistaxis (HP:0000421) | 1.85427843 |
| 134 | Increased serum lactate (HP:0002151) | 1.85401217 |
| 135 | Gangrene (HP:0100758) | 1.84846853 |
| 136 | Abnormality of T cells (HP:0002843) | 1.84759570 |
| 137 | Microvesicular hepatic steatosis (HP:0001414) | 1.83858933 |
| 138 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82554625 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.82536396 |
| 140 | Papillary thyroid carcinoma (HP:0002895) | 1.81510348 |
| 141 | Postural tremor (HP:0002174) | 1.80325306 |
| 142 | Muscle fiber atrophy (HP:0100295) | 1.80267105 |
| 143 | Abnormality of renal resorption (HP:0011038) | 1.79128089 |
| 144 | Orchitis (HP:0100796) | 1.79077593 |
| 145 | Rickets (HP:0002748) | 1.79069369 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.78292424 |
| 147 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78062209 |
| 148 | Hypophosphatemic rickets (HP:0004912) | 1.77918087 |
| 149 | Lethargy (HP:0001254) | 1.77707200 |
| 150 | Irregular epiphyses (HP:0010582) | 1.76810279 |
| 151 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.76451213 |
| 152 | Glycosuria (HP:0003076) | 1.76126687 |
| 153 | Abnormality of urine glucose concentration (HP:0011016) | 1.76126687 |
| 154 | Symptomatic seizures (HP:0011145) | 1.75927745 |
| 155 | Hepatocellular carcinoma (HP:0001402) | 1.75604602 |
| 156 | Oral leukoplakia (HP:0002745) | 1.75326280 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.75093386 |
| 158 | Neutropenia (HP:0001875) | 1.74743142 |
| 159 | Skin rash (HP:0000988) | 1.73451983 |
| 160 | Skin nodule (HP:0200036) | 1.73045974 |
| 161 | Uterine neoplasm (HP:0010784) | 1.71627604 |
| 162 | Recurrent viral infections (HP:0004429) | 1.71626726 |
| 163 | Lactic acidosis (HP:0003128) | 1.70373149 |
| 164 | Poor head control (HP:0002421) | 1.69874344 |
| 165 | Overlapping toe (HP:0001845) | 1.69780399 |
| 166 | Brittle hair (HP:0002299) | 1.69655272 |
| 167 | Hypoglycemic seizures (HP:0002173) | 1.67127400 |
| 168 | Meningitis (HP:0001287) | 1.66342581 |
| 169 | Retrobulbar optic neuritis (HP:0100654) | 1.65402545 |
| 170 | Optic neuritis (HP:0100653) | 1.65402545 |
| 171 | Nausea (HP:0002018) | 1.65036071 |
| 172 | Palpitations (HP:0001962) | 1.63444340 |
| 173 | Neonatal death (HP:0003811) | 1.63110923 |
| 174 | Glomerulosclerosis (HP:0000096) | 1.62099931 |
| 175 | Testicular neoplasm (HP:0010788) | 1.62083410 |
| 176 | Nephritis (HP:0000123) | 1.61754263 |
| 177 | Pterygium (HP:0001059) | 1.61297894 |
| 178 | Epiphyseal stippling (HP:0010655) | 1.59932540 |
| 179 | Hyperlipoproteinemia (HP:0010980) | 1.59414556 |
| 180 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.58272622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.97428529 |
| 2 | STK16 | 3.18910055 |
| 3 | EPHA2 | 2.92711308 |
| 4 | KIT | 2.46717846 |
| 5 | PAK4 | 2.38490698 |
| 6 | FLT3 | 2.37224897 |
| 7 | PIM2 | 2.26350230 |
| 8 | TEC | 2.19342760 |
| 9 | MST4 | 2.12482823 |
| 10 | MAP4K1 | 2.07689828 |
| 11 | PDK2 | 2.01396557 |
| 12 | NEK1 | 1.96139966 |
| 13 | IRAK4 | 1.94951953 |
| 14 | EIF2AK3 | 1.94669763 |
| 15 | BTK | 1.89014144 |
| 16 | FGFR4 | 1.85008573 |
| 17 | PBK | 1.83677690 |
| 18 | MAPKAPK5 | 1.83482143 |
| 19 | VRK1 | 1.82113904 |
| 20 | WEE1 | 1.71822855 |
| 21 | STK38L | 1.71750631 |
| 22 | VRK2 | 1.71128355 |
| 23 | LMTK2 | 1.70110310 |
| 24 | ACVR1B | 1.68307914 |
| 25 | PIK3CA | 1.68298769 |
| 26 | TGFBR1 | 1.67466979 |
| 27 | SCYL2 | 1.66921814 |
| 28 | TNIK | 1.64037680 |
| 29 | LATS2 | 1.61425827 |
| 30 | BLK | 1.57437708 |
| 31 | KDR | 1.55437183 |
| 32 | CDK19 | 1.55254758 |
| 33 | TXK | 1.50440564 |
| 34 | BUB1 | 1.50424105 |
| 35 | FER | 1.50185255 |
| 36 | CSF1R | 1.49346099 |
| 37 | BRSK2 | 1.48560879 |
| 38 | BCKDK | 1.42184147 |
| 39 | TRIM28 | 1.40837893 |
| 40 | TTK | 1.39337537 |
| 41 | ZAP70 | 1.38416591 |
| 42 | STK24 | 1.36426194 |
| 43 | PKN2 | 1.34165770 |
| 44 | TBK1 | 1.34145055 |
| 45 | NLK | 1.31333079 |
| 46 | PASK | 1.30570721 |
| 47 | TGFBR2 | 1.30535429 |
| 48 | BCR | 1.29830352 |
| 49 | EIF2AK1 | 1.28287285 |
| 50 | JAK3 | 1.24618951 |
| 51 | MAP3K12 | 1.23509666 |
| 52 | STK3 | 1.22496985 |
| 53 | WNK4 | 1.22140280 |
| 54 | TAOK3 | 1.21921400 |
| 55 | IKBKE | 1.19597479 |
| 56 | RIPK1 | 1.19576636 |
| 57 | IRAK3 | 1.18774122 |
| 58 | TYK2 | 1.18614359 |
| 59 | MUSK | 1.18159935 |
| 60 | TESK2 | 1.17729653 |
| 61 | RPS6KB2 | 1.17356254 |
| 62 | TIE1 | 1.15548664 |
| 63 | TSSK6 | 1.15510102 |
| 64 | MST1R | 1.13094203 |
| 65 | MKNK1 | 1.12244155 |
| 66 | DYRK3 | 1.11934425 |
| 67 | PLK3 | 1.10534836 |
| 68 | LATS1 | 1.09563466 |
| 69 | FGFR1 | 1.07752571 |
| 70 | ERBB3 | 1.06663680 |
| 71 | TRPM7 | 1.05812607 |
| 72 | FGFR2 | 1.05583903 |
| 73 | ADRBK2 | 1.05364020 |
| 74 | PTK2 | 1.03682468 |
| 75 | IKBKB | 1.03349658 |
| 76 | FGFR3 | 1.03050183 |
| 77 | LRRK2 | 1.02598445 |
| 78 | SYK | 1.02586850 |
| 79 | MAPKAPK3 | 0.99838197 |
| 80 | BRSK1 | 0.98537877 |
| 81 | ITK | 0.98272531 |
| 82 | MAP3K2 | 0.97965011 |
| 83 | MAP3K14 | 0.97365422 |
| 84 | MAP3K3 | 0.96188562 |
| 85 | BMPR1B | 0.95490890 |
| 86 | MAP2K3 | 0.90385594 |
| 87 | PDGFRA | 0.89021747 |
| 88 | LYN | 0.87855813 |
| 89 | MYLK | 0.86923877 |
| 90 | CSNK1G3 | 0.85551000 |
| 91 | PIK3CG | 0.85384195 |
| 92 | PTK6 | 0.84223364 |
| 93 | PHKG1 | 0.84117844 |
| 94 | PHKG2 | 0.84117844 |
| 95 | LCK | 0.83310098 |
| 96 | SRPK1 | 0.81822264 |
| 97 | ARAF | 0.80678560 |
| 98 | STK39 | 0.79805526 |
| 99 | NME1 | 0.79640739 |
| 100 | MAPK15 | 0.78374447 |
| 101 | RPS6KA4 | 0.78065925 |
| 102 | MAP2K6 | 0.76817619 |
| 103 | CDK8 | 0.75508077 |
| 104 | GRK1 | 0.74581354 |
| 105 | ERBB4 | 0.74069504 |
| 106 | LIMK1 | 0.73786750 |
| 107 | SIK1 | 0.73288280 |
| 108 | NEK6 | 0.70674601 |
| 109 | EIF2AK2 | 0.70382984 |
| 110 | EPHB1 | 0.70219024 |
| 111 | AKT2 | 0.69977470 |
| 112 | INSRR | 0.68650758 |
| 113 | ILK | 0.68363593 |
| 114 | MAP2K2 | 0.68233081 |
| 115 | RPS6KA5 | 0.68150846 |
| 116 | MATK | 0.67354052 |
| 117 | CCNB1 | 0.66194809 |
| 118 | CLK1 | 0.64680172 |
| 119 | MET | 0.62871777 |
| 120 | ICK | 0.59603617 |
| 121 | OXSR1 | 0.59473489 |
| 122 | ERN1 | 0.59293401 |
| 123 | CSNK1G1 | 0.59024033 |
| 124 | BMX | 0.58975729 |
| 125 | TAF1 | 0.58363885 |
| 126 | ABL2 | 0.57500263 |
| 127 | NEK9 | 0.57363266 |
| 128 | DYRK2 | 0.57313751 |
| 129 | PRKCI | 0.56978902 |
| 130 | RPS6KB1 | 0.55414891 |
| 131 | PIM1 | 0.55358923 |
| 132 | AURKB | 0.55349657 |
| 133 | GRK5 | 0.54944191 |
| 134 | TESK1 | 0.54274689 |
| 135 | STK10 | 0.54032503 |
| 136 | CSNK1E | 0.53752268 |
| 137 | MAP3K9 | 0.53719050 |
| 138 | TLK1 | 0.52360294 |
| 139 | MAP3K11 | 0.51944125 |
| 140 | CSNK1A1L | 0.51139304 |
| 141 | CDK7 | 0.50540588 |
| 142 | IRAK1 | 0.49915834 |
| 143 | PLK2 | 0.49825450 |
| 144 | CSNK2A1 | 0.47782592 |
| 145 | MAPK4 | 0.47697338 |
| 146 | PLK1 | 0.47416654 |
| 147 | MAPKAPK2 | 0.46616546 |
| 148 | PRKG2 | 0.46515845 |
| 149 | CASK | 0.44548136 |
| 150 | CAMK2D | 0.44465991 |
| 151 | NUAK1 | 0.44426276 |
| 152 | TRIB3 | 0.43657939 |
| 153 | CDK6 | 0.41848260 |
| 154 | RPS6KA6 | 0.41008201 |
| 155 | YES1 | 0.39868818 |
| 156 | CSNK2A2 | 0.38947047 |
| 157 | MAP2K1 | 0.36241996 |
| 158 | DMPK | 0.36014123 |
| 159 | PNCK | 0.32996571 |
| 160 | CSNK1A1 | 0.31245674 |
| 161 | GSK3A | 0.30250913 |
| 162 | SIK3 | 0.30232120 |
| 163 | CSNK1G2 | 0.30144170 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.05839232 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.95259037 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.02612038 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.88915896 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50590103 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.41545044 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39155285 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26543344 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25708035 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.14386341 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.10449807 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00884868 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.96300536 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89849481 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.83676531 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.82540653 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76173453 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.73832002 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69597987 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61248944 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59326744 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58486764 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54005819 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52514410 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.48905584 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.48875473 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.46905105 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.44524324 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44287647 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.43898632 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41033566 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40865025 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40421424 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39729869 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.39560680 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37986359 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.36417041 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35488805 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.33926291 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.33314108 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33216151 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29957921 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28793888 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28726749 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28200734 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.27572477 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26792924 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26685770 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26669854 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26555488 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23008127 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22574417 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19559995 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19058886 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19007573 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18525280 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.17501911 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17003652 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16294275 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12926037 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11209795 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09575523 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07980010 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06309540 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06153815 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 1.05569244 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.05261802 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 1.03269829 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02925751 |
| 70 | RNA degradation_Homo sapiens_hsa03018 | 1.02201867 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99972527 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99680129 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99198845 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99144161 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.98187075 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98115422 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95587927 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95471583 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94667475 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93932065 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93496130 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92468439 |
| 83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.91836310 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90041156 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90030288 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89164779 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86847816 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86214810 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.84934549 |
| 90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.83773502 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82310148 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81900170 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80141431 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.79781740 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78042282 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77649302 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76289149 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75957616 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75060466 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.74855776 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74137743 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.74037143 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73652046 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71443975 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69769302 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.68773573 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.67913679 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60410728 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.59326562 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58984938 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58287928 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.57846858 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57292185 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56818136 |
| 115 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56777682 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56758188 |
| 117 | Asthma_Homo sapiens_hsa05310 | 0.56534724 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55689856 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55349742 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54529980 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54490468 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54289991 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54218641 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50152840 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.48261045 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.48090541 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47547023 |
| 128 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46647811 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46590666 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.45766945 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44946483 |
| 132 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44638422 |
| 133 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43886419 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.43742653 |
| 135 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43541465 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41157508 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40861549 |
| 138 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40709100 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40625754 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39777520 |
| 141 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36442129 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36396683 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35756122 |
| 144 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31593990 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31117779 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29719999 |

